Oaktree Acquisition Corp. III Life Sciences (OACC) Notes Payables (2024 - 2026)
Oaktree Acquisition Corp. III Life Sciences filings provide 3 years of Notes Payables readings, the most recent being $11824.0 for Q1 2026.
- Quarterly Notes Payables changed 0.0% to $11824.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $11824.0 through Mar 2026, changed 0.0% year-over-year, with the annual reading at $11824.0 for FY2025, 0.0% changed from the prior year.
- Notes Payables hit $11824.0 in Q1 2026 for Oaktree Acquisition Corp. III Life Sciences, roughly flat from $11824.0 in the prior quarter.
- Across five years, Notes Payables topped out at $11824.0 in Q4 2024 and bottomed at $11824.0 in Q4 2024.
- Average Notes Payables over 3 years is $11824.0, with a median of $11824.0 recorded in 2024.
- Peak annual rise in Notes Payables hit 0.0% in 2025, while the deepest fall reached 0.0% in 2025.
- Oaktree Acquisition Corp. III Life Sciences' Notes Payables stood at $11824.0 in 2024, then changed by 0.0% to $11824.0 in 2025, then changed by 0.0% to $11824.0 in 2026.
- Per Business Quant, the three most recent readings for OACC's Notes Payables are $11824.0 (Q1 2026), $11824.0 (Q4 2025), and $11824.0 (Q3 2025).